Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy
- 14 September 2000
- journal article
- clinical trial
- Published by Elsevier in Epilepsy Research
- Vol. 42 (1) , 23-31
- https://doi.org/10.1016/s0920-1211(00)00160-1
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Adding Lamotrigine to Valproate: Incidence of Rash and Other Adverse EffectsEpilepsia, 1999
- Pharmacokinetics of Lamotrigine in Children in the Absence of other Antiepileptic DrugsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999
- Lamotrigine Plasma Concentrations in Children and AdultsTherapeutic Drug Monitoring, 1997
- Use of Lamotrigine in Lennox-Gastaut and Related Epilepsy SyndromesJournal of Child Neurology, 1997
- Lamotrigine as add-on drug in children and adolescents with refractory epilepsy and mental delay: an open trialBrain & Development, 1997
- The Influence of Dosage, Age, and Comedication on Steady State Plasma Lamotrigine Concentrations in Epileptic ChildrenTherapeutic Drug Monitoring, 1997
- A naturalistic study of the use of vigabatrin, lamotrigine and gabapentin in adults with learning disabilitiesSeizure, 1997
- Lamotrigine substitution study: evidence for synergism with sodium valproate?Epilepsy Research, 1997
- Therapeutic interaction of lamotrigine and sodium valproate in intractable myoclonic epilepsySeizure, 1994
- Lamotrigine, a new anticonvulsant: Pharmacokinetics in normal humansClinical Pharmacology & Therapeutics, 1987